Human Papillomavirus Vaccine Hesitancy in the United States
Although the US Advisory Committee on Immunization Practices recommends vaccinating adolescents against the human papillomavirus (HPV) to prevent HPV-associated cancers, vaccine initiation and completion rates are suboptimal. Parental and provider hesitancy contributes significantly to low HPV vaccine uptake. This review describes sources of HPV vaccine hesitancy using a World Health Organization framework that categorizes determinants of vaccine hesitancy as follows: contextual factors (historical, sociocultural, environmental, or political factors), individual and group factors (personal perception or influences of the social/peer environment), and vaccine/vaccination-specific issues (directly related to vaccine or vaccination).
Source: Pediatric Clinics of North America - Category: Pediatrics Authors: Daisy Y. Morales-Campos, Gregory D. Zimet, Jessica A. Kahn Source Type: research
More News: Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer Vaccines | Cervical Cancer Vaccine | Environmental Health | Gardasil | Genital Warts | History of Medicine | Human Papillomavirus (HPV) | International Medicine & Public Health | Pediatrics | Politics | USA Health | Vaccines | WHO